DelMar Pharmaceuticals Archives - Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Friedman Ference Congratulates DelMar Pharmaceuticals, Inc. on NASDAQ Uplisting

By Sichenzia Ross Ference LLP | July 11, 2016

New York, NY – July 11, 2016 – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno. not assigned nasdaq | pharmaceutical | srff | uplisting